The Main Characteristics of New Oral Anticoagulant with Anti-Xa Activity (IMAGE)
Caption
New oral anticoagulants (NOACs) represent direct-acting drugs functioning selectively for one specific clotting factor. Their clinical indications are the prophylaxis and treatment of deep venous thrombosis and pulmonary embolism, the prevention of atherothrombotic episodes of individuals with acute coronary syndromes and atrial fibrillation
Credit
Dr. Peter Kubisz et al, Bentham Science Publishers
Usage Restrictions
None
License
Licensed content